Filter News
Area of Research
- (-) Computational Engineering (1)
- (-) National Security (3)
- (-) Neutron Science (23)
- (-) Nuclear Science and Technology (4)
- Advanced Manufacturing (4)
- Biological Systems (1)
- Clean Energy (19)
- Climate and Environmental Systems (1)
- Computer Science (8)
- Fusion Energy (2)
- Materials (41)
- Quantum information Science (3)
- Supercomputing (31)
- Transportation Systems (1)
News Type
News Topics
- (-) Artificial Intelligence (2)
- (-) Biomedical (4)
- (-) Computer Science (6)
- (-) Materials Science (3)
- (-) Microscopy (1)
- (-) Neutron Science (22)
- 3-D Printing/Advanced Manufacturing (1)
- Advanced Reactors (4)
- Big Data (2)
- Bioenergy (2)
- Clean Water (1)
- Composites (1)
- Cybersecurity (1)
- Energy Storage (3)
- Environment (4)
- Fusion (1)
- Grid (1)
- Isotopes (2)
- Machine Learning (3)
- Molten Salt (3)
- Nanotechnology (1)
- Nuclear Energy (15)
- Physics (3)
- Quantum Science (1)
- Security (2)
- Space Exploration (2)
- Transportation (2)
Media Contacts
![Radiochemical technicians David Denton and Karen Murphy use hot cell manipulators at Oak Ridge National Laboratory during the production of actinium-227. Radiochemical technicians David Denton and Karen Murphy use hot cell manipulators at Oak Ridge National Laboratory during the production of actinium-227.](/sites/default/files/styles/list_page_thumbnail/public/2016-P07827%5B1%5D.jpg?itok=yJbnFQLU)
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.